Advanced Immune Therapeutics (United States)

Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer

Jonathan S. Berek, Peyton T. Taylor, William P. McGuire et al. · Journal of Clinical Oncology · 2008 · 172 citations

Medicine, Gynecology, Oncology +17

The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian Cancer

Patricia S. Braly, Christopher F. Nicodemus, Christina Chu et al. · Journal of Immunotherapy · 2008 · 62 citations

Medicine, Immunology, Oncology +17

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

Tracy R. Daniels‐Wells, Gustavo Helguera, Richard K. Leuchter et al. · BMC Cancer · 2013 · 52 citations · Full text

Medicine, Immunology, Oncology +17

Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells

Tracy R. Daniels‐Wells, Richard K. Leuchter, Rafaela Quintero et al. · Cancer Immunology Immunotherapy · 2011 · 43 citations · Full text

Life Sciences, Immunology, Oncology +16

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI‐mediated basophil activation by a tumour‐specific IgE antibody to evaluate the risk of type I hypersensitivity

Sarah Maria Rudman, Debra H. Josephs, Helen Cambrook et al. · Clinical & Experimental Allergy · 2011 · 41 citations

Life Sciences, Immunology, Oncology +17